- Home
- LE vs AMLX Comparison
LE vs AMLX Comparison
Compare LE & AMLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LE
- AMLX
- Stock Information
- Founded
- LE 1963
- AMLX 2014
- Country
- LE United States
- AMLX United States
- Employees
- LE N/A
- AMLX N/A
- Industry
- LE Clothing/Shoe/Accessory Stores
- AMLX Biotechnology: Pharmaceutical Preparations
- Sector
- LE Consumer Discretionary
- AMLX Health Care
- Exchange
- LE Nasdaq
- AMLX Nasdaq
- Market Cap
- LE 323.8M
- AMLX 330.5M
- IPO Year
- LE N/A
- AMLX 2022
- Fundamental
- Price
- LE $8.67
- AMLX $5.36
- Analyst Decision
- LE Strong Buy
- AMLX Buy
- Analyst Count
- LE 2
- AMLX 4
- Target Price
- LE $20.00
- AMLX $8.50
- AVG Volume (30 Days)
- LE 154.5K
- AMLX 874.8K
- Earning Date
- LE 06-04-2025
- AMLX 05-08-2025
- Dividend Yield
- LE N/A
- AMLX N/A
- EPS Growth
- LE N/A
- AMLX N/A
- EPS
- LE 0.20
- AMLX N/A
- Revenue
- LE $1,362,935,000.00
- AMLX $87,371,000.00
- Revenue This Year
- LE $4.26
- AMLX N/A
- Revenue Next Year
- LE $2.67
- AMLX N/A
- P/E Ratio
- LE $43.17
- AMLX N/A
- Revenue Growth
- LE N/A
- AMLX N/A
- 52 Week Low
- LE $8.15
- AMLX $1.58
- 52 Week High
- LE $19.88
- AMLX $7.27
- Technical
- Relative Strength Index (RSI)
- LE 39.90
- AMLX 78.34
- Support Level
- LE $8.26
- AMLX $3.79
- Resistance Level
- LE $9.24
- AMLX $4.05
- Average True Range (ATR)
- LE 0.62
- AMLX 0.34
- MACD
- LE 0.02
- AMLX 0.19
- Stochastic Oscillator
- LE 31.04
- AMLX 95.54
About LE Lands' End Inc.
Lands' End Inc is a United States-based multi-channel retailer of casual clothing, accessories, and footwear, as well as home products. The company's operating segment includes U.S. eCommerce; International; Outfitters; Third Party and Retail. It generates maximum revenue from the U.S. eCommerce segment. The U.S. eCommerce segment offers products through the company's eCommerce website. Geographically, it derives a majority of its revenue from the United States.
About AMLX Amylyx Pharmaceuticals Inc.
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder and endocrine conditions.